Want to join the conversation?
In 3Q16, $ISRG's US procedures grew approx. 11% and outside of the US, procedures grew approx. 25%. In the United States, combined growth in mature procedures slowed in 3Q16. General and thoracic procedure growth remained healthy. In US gynaecology, procedures in 3Q16 grew modestly YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?